Home › Trial NCT01703507
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
- Trial IDNCT01703507
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Enrollment17
- Start date2012-11-09
- ConditionsRecurrent Melanoma · Stage IV Melanoma · Tumors Metastatic to Brain
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.